2014Sichuan Mental HealthOpen access

Meta-analysis of comparative study of duloxetine in the treatment of senile depression

Wang Gang-pin

Open full text 0 citations

Abstract

Objective To study the difference of efficacy and side effect of duloxetine in the treatmrent of senile depression.Methods 10 comparative studies of duloxetine and other antidepressants in the treatment of senile depression were analyzed by meta-analysis. Results 1Self- comparison study of duloxetine before and after treatment showed that d = 4. 59,95% CI( 3. 01,6. 17),χ2=21. 5,P 0. 01. Comparison between duloxetine and the controlled antidepressants at 2 weeks treatment and at the end of each tril showed that Yco=- 0. 04,95% CI(- 0. 19,0. 11),χ2= 3. 86,P 0. 05,and Yco= 0. 01,95% CI(- 0. 14,0. 17),χ2= 3. 06,P 0. 05 respectiveiy,which revealed that there was no significant difference between duloxetine and the controlled antidepressants with respect to the clinical efficacy. There were no significant difference in side effect between these two groups. Conclusion Duloxetine is an safe and effective antidepressant in the treatment of senile depression.

About this research paper

What this paper is about

Objective To study the difference of efficacy and side effect of duloxetine in the treatmrent of senile depression.Methods 10 comparative studies of duloxetine and other antidepressants in the treatment of senile depression were analyzed by meta-analysis. Results 1Self- comparison study of duloxetine before and after treatment showed that d = 4. 59,95% CI( 3. 01,6. 17),χ2=21. 5,P 0. 01. Comparison between duloxetine and the controlled antidepressants at 2 weeks treatment and at the end of each tril showed that Yco=- 0. 04,95% CI(- 0. 19,0. 11),χ2= 3. 86,P 0. 05,and Yco= 0. 01,95% CI(- 0. 14,0. 17),χ2= 3. 06,P 0. 05 respectiveiy,which revealed that there was no significant difference between duloxetine and the controlled antidepressants with respect to the clinical efficacy. There were no significant difference in side effect between these two groups. Conclusion Duloxetine is an safe and effective antidepressant in the treatment of senile depression.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the difference of efficacy and side effect of duloxetine in the treatmrent of senile depression.Methods 10 comparative studies of duloxetine and other antidepressants in the treatment of senile depression were analyzed by meta-analysis. Results 1Self- comparison study of duloxetine before and after treatment showed that d = 4. 59,95% CI( 3. 01,6. 17),χ2=21. 5,P 0. 01. Comparison between duloxetine and the controlled antidepressants at 2 weeks treatment and at the end of each tril showed that Yco=- 0. 04,95% CI(- 0. 19,0. 11),χ2= 3. 86,P 0. 05,and Yco= 0. 01,95% CI(- 0. 14,0. 17),χ2= 3. 06,P 0. 05 respectiveiy,which revealed that there was no significant difference between duloxetine and the controlled antidepressants with respect to the clinical efficacy. There were no significant difference in side effect between these two groups. Conclusion Duloxetine is an safe and effective antidepressant in the treatment of senile depression.

Key concepts: Duloxetine, Depression (economics), Duloxetine Hydrochloride, Significant difference, Internal medicine, Medicine, Antidepressant, Clinical efficacy

Related papers

Back to paper searchBrowse research topicsOriginal source
Meta-analysis of comparative study of duloxetine in the treatment of senile depression — Research Paper | ScholarLens